Commentary & Deal Flow

Reoffer: Long 3yr: MS+30bp / 99.998 / 3.407% 6yr: MS+50bp / 100 / 3.652% 9yr: MS+68bp / 100 / 3.923% 12yr: MS+83bp / 100 / 4.169%
Benchmark: Long 3yr: DBR 0.000 15-Feb-30 @ 90.585 / B+52.0bp HR 106% 6yr: DBR 1.700 15-Aug-32 @ 92.945 / B+64.3bp HR 103% 9yr: DBR 2.600 15-Aug-35 @ 95.39 / B+72.4bp HR 100% 12yr: DBR 1.000 15-May-38 @ 77.11 / B+76.8bp HR 113%

Tranche 1 (Long 3yr): Peak book >€2.0bn
Tranche 2 (6yr): Peak book >€2.1bn
Tranche 3 (9yr): Peak book >€1.6bn
Tranche 4 (12yr): Peak book >€2.7bn
Combined Peak book above €8.5bn (pre-rec)

Launched:
Long 3yr: €700m @ MS+30bp - Books >€1.9bn
6yr: €600m @ MS+50bp - Books >€1.7bn
9yr: €500m @ MS+68bp - Books >€1.4bn
12yr: €750m @ MS+83bp - Books >€1.8bn
Spread set at: Long 3yr: MS+30bp 6yr: MS+50bp 9yr: MS+68bp 12yr: MS+83bp - Combined Books above €6.8bn (pre-rec)
Guidance:
Long 3yr: MS+30/35bp - Books >€2.0bn
6yr: MS+50/55bp - Books >€2.1bn
9yr: MS+70a (+/-2) - Books >€1.6bn
12yr: MS+85a (+/-2) - Books >€2.7bn
Combined Books above €8.5bn (pre-rec)
IPTs:
Long 3yr: MS+60a
6yr: MS+80a
9yr: MS+95/100bp
12yr: MS+115a

• Issuer: AstraZeneca Finance LLC (Ticker: AZN)
• Issuer LEI: 549300C3HATU4Q460S18
• Guarantor: AstraZeneca PLC
• Guarantor LEI: PY6ZZQWO2IZFZC3IOL08
• Guarantor Ratings: A1 (positive) / A+ (stable) (Moody's / S&P)
• Expected Issue Ratings: A1 / A+ (Moody's / S&P)
• Format of the Notes: Senior, Unsecured, Reg S, Registered, NSS
• Size:
  • Long 3yr: €700m
  • 6yr: €600m
  • 9yr: €500m
  • 12yr: €750m
• Tenor:
  • Long 3yr: Long 3-year
  • 6yr: 6-year
  • 9yr: 9-year
  • 12yr: 12-year
• Settlement Date: 01-Sep-26 (T+5)
• Maturity Date:
  • Long 3yr: 01-Mar-30
  • 6yr: 01-Sep-32
  • 9yr: 01-Sep-35
  • 12yr: 01-Sep-38
• Reoffer:
  • Long 3yr: 99.998 / MS+30bp / 3.407%
  • 6yr: 100 / MS+50bp / 3.652%
  • 9yr: 100 / MS+68bp / 3.923%
  • 12yr: 100 / MS+83bp / 4.169%
• Benchmark Spread:
  • Long 3yr: DBR 0.000 15-Feb-30 + 52.0 (px: 90.585) HR 106%
  • 6yr: DBR 1.700 15-Aug-32 + 64.3 (px: 92.945) HR 103%
  • 9yr: DBR 2.600 15-Aug-35 + 72.4 (px: 95.39) HR 100%
  • 12yr: DBR 1.000 15-May-38 + 76.8 (px: 77.11) HR 113%
• Coupon:
  • Long 3yr: 3.402%, Fixed, Ann, Act / Act (ICMA), Short First
  • 6yr: 3.652%, Fixed, Ann, Act / Act (ICMA)
  • 9yr: 3.923%, Fixed, Ann, Act / Act (ICMA)
  • 12yr: 4.169%, Fixed, Ann, Act / Act (ICMA)
• Denominations: €100k + 1k
• Business Days: London, T2
• Early Redemption: 1m Par Call (Long 3-year), 3m Par Call (6-, 9- and 12-years), MWC, Clean-up Call (75%)
• ISIN / Common Code:
  • Long 3yr: XS3484302206 / 348430220
  • 6yr: XS3484302461 / 348430246
  • 9yr: XS3484302545 / 348430254
  • 12yr: XS3484302628 / 348430262
• UOP: General Corporate Purposes
• Docs: Euro Medium Term Note Programme dated 09-Jun-26, London Stock Exchange (Main Market), English Law
• Canadian Sales: Yes, via exemption
• Target Market: MiFID II and UK MiFIR professionals/ECPs-only / No EEA PRIIPs KID or DISC disclosure document – Manufacturer target market (MiFID II product governance and UK MiFIR product governance rules) is eligible counterparties and professional clients only (all distribution channels). No EEA PRIIPs key information document (“KID”) or disclosure document required by the FCA Product Disclosure Sourcebook (“DISC”) has been prepared as the Notes are not deemed within scope / not available to retail in the EEA or the United Kingdom
• Advertisement: The Base Prospectus is available on the London Stock Exchange www.londonstockexchange.com/exchange/news/market-news/market-news-home and the Final Terms, when published, will also be available on the same website
• Active Bookrunners: Barclays, Goldman Sachs International, Morgan Stanley (B&D)
• B&D: Morgan Stanley
• Timing: PRICED
• TOE: Long-3yr 16:05 UKT / 17:05 CET; 6yr 16:04 UKT / 17:04 CET; 9 yr 16:04 UKT / 17:04 CET; 16:03 UKT / 16:03 CET
• FTT: 16:45 UKT / 17:45 CET